FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. II. In vitro and in vivo activities

Journal of Antibiotics

Volumn 53, Issue 9, 2000, Pages 920-927

  Fujie, A ^a   Iwamoto, T ^a   Muramatsu, H ^a   Okudaira, T ^a   Sato, I ^a   Furuta, T ^a   Tsurumi, Y ^a   Hori, Y ^a   Hino, M ^a   Hashimoto, S ^a   Okuhara, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACULEACIN A; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CILOFUNGIN; CYCLOPHOSPHAMIDE; ECHINOCANDIN B; ECHINOCANDIN B DERIVATIVE; ENZYME INHIBITOR; FLUCONAZOLE; FR 901469; GLUCAN SYNTHASE; HEPARIN; LACTONE DERIVATIVE; LIPOPEPTIDE; MACROGOL 400; RICINOMACROGOL; SODIUM CHLORIDE; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG; VINYL DERIVATIVE; WF 11899 A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SOLUBILITY; ERYTHROCYTE; FEMALE; FUNGUS CULTURE; HEMOLYSIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SYSTEMIC MYCOSIS;

ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; PNEUMOCYSTIS;

EID: 0033779085     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.53.920     Document Type: Article

References (25)

1. FR901469, a novel antifungal antibiotic from an identified fungus No. 11243. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological properties
2. WF11899A, B, and C, novel antifungal lipopeptides. II. Biological properties
3. FR901379, A novel antifungal antibiotic
4. On the mode of action of a new antifungal antibiotic, aculeacin A: Inhibition of cell wall synthesis in Saccharomyces cerevisiae
5. Studies on the mechanism of antifungal action of aculeacin A
6. Echinocandin inhibition of 1,3-β-D-glucan synthase from Candida albicans
7. L-687,781, A new member of the papulacandin family of β-1,3-D-glucan synthesis inhibitors
8. Cell envelope of Candida albicans
9. Antibiotics that inhibit fungal cell wall development
10. WF11899A, B, and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties
11. Pneumocandins from Zalerion arboricola, IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species
12. Mulundocandin, an echinocandin like lipopeptide antifungal agent: Biological activities in vitro
13. Studies on aculeacin. I. Isolation and characterization of aculeacin A
14. 0
15. Papulacandins, a new family of antibiotics with antifungal activity. I. Fermentation, isolation, chemical and biological characterization of papulacandins A, B, C, D and E
16. Therapeutic effects of water-soluble echinocandin compounds on Pneumocystis pneumonia in mice
17. Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats
18. In vitro evaluation of the pneumocandin antifungal agent L-733,560, a new water-soluble hybrid of L-705,589 and L-731,373
19. Synthesis and evaluation of LY121019, a member of a series of semisynthetic analogues of the antifungal lipopeptide echinocandin B
20. L-671,329, a new antifungal agent. III. In vitro activity, toxicity and efficacy in comparison to aculeacin
21. Deacylation of echinocandin B by Actinoplanes utahensis
22. FK463, a novel water-soluble echinocandin lipopeptide: Synthesis and antifungal activity
23. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi
24. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis
25. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis